Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

45.22
+0.56001.25%
Post-market: 44.94-0.2800-0.62%16:55 EDT
Volume:2.93M
Turnover:132.39M
Market Cap:3.60B
PE:-12.04
High:45.92
Open:44.28
Low:43.91
Close:44.66
Loading ...

Akero Therapeutics, Inc. (AKRO): the Best Performing Healthcare Stock So Far in 2025

Insider Monkey
·
20 Feb

Akero Therapeutics Inc. (AKRO): Among The Stocks That Started The Year On A High

Insider Monkey
·
04 Feb

Why Akero Therapeutics (AKRO) Is Among the Best Booming Stocks to Invest in Now?

Insider Monkey
·
03 Feb

Akero Therapeutics Is Maintained at Buy by UBS

Dow Jones
·
01 Feb

UBS Adjusts Price Target on Akero Therapeutics to $109 From $42, Keeps Buy Rating

MT Newswires Live
·
01 Feb

89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’

TIPRANKS
·
31 Jan

Press Release: Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
31 Jan

Stock Track | Akero Therapeutics Soars 5.76% on Analyst Upgrade and Optimistic Price Target

Stock Track
·
30 Jan

BofA Securities Upgrades Akero Therapeutics to Buy, $63 Price Target

MT Newswires Live
·
30 Jan

Akero Therapeutics Raised to Buy From Neutral by B of A Securities

Dow Jones
·
30 Jan

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates

Zacks
·
30 Jan

AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study

Zacks
·
29 Jan

Stock Track | Akero Therapeutics Soars 5.95% Following $350 Million Equity Raise and Positive Drug Study

Stock Track
·
29 Jan

BUZZ-Akero Therapeutics gains after upsized $350 mln equity raise

Reuters
·
29 Jan

Akero Therapeutics 5.333M share Secondary priced at $48.00

TIPRANKS
·
29 Jan

Akero Therapeutics Prices $350 Million Upsized Public Offering

MT Newswires Live
·
29 Jan